Advances in Chronic Kidney Disease
Volume 11, Issue 4 , Pages 361-370 , October 2004

Outcomes associated with hypogonadism in women with chronic kidney disease

  • José R. Weisinger

      Affiliations

    • Division of Nephrology, Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela
    • Corresponding Author InformationAddress correspondence to José R. Weisinger, MD, FACP, Division of Nephrology, Hospital Universitario de Caracas, Universidad Central de Venezuela, Apartado Postal 47365, Los Chaguaramos, Caracas, Venezuela
    • ,
  • Ezequiel Bellorin-Font

      Affiliations

    • Division of Nephrology, Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela

References 

  1. Gipson D , Katz LA , Stehman-Breen C . Principles of dialysis (Special issues in women) . Semin Nephrol . 1999;19:140–147
  2. Erlik Y , Tataryn IV , Medrum DR , et al.   Association of walking episodes with menopausal hot flushes . JAMA . 1981;24:1741–1744
  3. Pearlstein T , Rosen K , Stone AB . Mood disorders and menopause . Endocrinol Metab Clin North Am . 1997;26:279–294
  4. Toorians AW , Janssen E , Laan E , et al.   Chronic renal failure and sexual functioning (Clinical status versus objectively assessed sexual response) . Nephrol Dial Transplant . 1997;12:2654–2663
  5. Lim VS , Henriquez C , Sieversten G , et al.   Ovarian function in chronic renal failure. Evidence of hypothalamic anovulation . Ann Intern Med . 1980;92:21–27
  6. Lim VS , Kathpalia SC , Frohman LA . Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure (Reversal after transplantation) . J Clin Endocrinol Metab . 1979;48:101–107
  7. Sarrel PM . Ovarian hormones and vaginal blood flow (Using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women) . Int J Impot Res . 1998;10(suppl):S91–S93
  8. Milde FK , Hart LK , Fearing MO . Sexuality and fertility concerns of dialysis patients . ANNA J . 1996;23:307–313
  9. Mastrogiacomo I , De Besi L , Serafini E , et al.   Hyperprolactinemia and sexual disturbances among uremic women on hemodialysis . Nephron . 1984;37:195–199
  10. Greendale GA , Lee NP , Arriola ER . The menopause . Lancet . 1999;353:571–580
  11. Maheux R , Naud F , Rioux M , et al.   A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness . Am J Obstet Gynecol . 1994;170:642–649
  12. Tercedor J , Lopez-Hernandez B , Rodenas JM , et al.   Multivariate analysis of cutaneous markers of aging in chronic hemodialyzed patients . Int J Dermatol . 1995;34:546–550
  13. Weisinger JR , Bellorin-Font E . Postmenopausal osteoporosis in the dialysis patient . Curr Opin Nephrol Hypertens . 2003;12:381–386
  14. Elder G . Pathophysiology and recent advances in the management of renal osteodystrophy . J Bone Miner Res . 2002;17:2094–2105
  15. Weisinger JR . Role of hormone replacement in the management of osteoporosis in haemodialysed women (Perspectives for the future) . Nephrol Dial Transplant . 2000;15(suppl):S36–S37
  16. Lindberg JS , Moe SM . Osteoporosis in end stage renal disease . Semin Nephrol . 1999;19:115–122
  17. US Renal Data System . USRDS 2002 Annual Data Report . Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Renal Diseases; 2002;
  18. Registry of the European Renal Association/European Dialysis and Transplantation Association. Available at http://www.era-edta-reg.org
  19. Mazzuchi N , González-Martínez  , Schwedt E , et al.   Incidence and prevalence of the treatment of end stage renal disease in Latin America . Nefrología Latinoamericana . 1999;6:154–159
  20. Infante M, Hernandez E, Rojas E, et al: The spectrum of bone disease in chronic kidney disease (CKD) stages 3 to 5: Possible contribution of osteoporosis. Abstract. Annual Meeting of the American Society of Nephology, San Diego, CA, November 12-17, 2003
  21. Cummings S , Nevitt M , Browner W , et al.   Risk factors for hip fracture in white women (Study of osteoporotic fractures research group) . N Engl J Med . 1995;332:767–773
  22. Alem AM , Sherrard DJ , Gillen DL , et al.   Increased risk of hip fracture among patients with end-stage renal disease . Kidney Int . 2000;58:396–399
  23. Hodsman AB . Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated? . Perit Dial Int . 2001;21(suppl):S247–S255
  24. Fontaine MA , Albert A , Dubois B , et al.   Fracture and bone mineral density in hemodialysis patients . Clin Nephrol . 2000;54:218–226
  25. Jamal SA , Chase C , Goh YI , et al.   Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures . Am J Kidney Dis . 2002;39:843–849
  26. Hsu C , Cummings SR , McCulloch CE , et al.   Bone mineral density is not diminished by mild to moderate chronic renal insufficiency . Kidney Int . 2002;61:1814–1820
  27. Kaji H , Suzuki M , Yano S , et al.   Risk factors for hip fractures in hemodialysis patients . Am J Nephrol . 2002;22:325–331
  28. Coco M , Rush H . Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone . Am J Kidney Dis . 2002;36:1115–1121
  29. Atsumi K , Kushida K , Yamazaki K , et al.   Risk factors for vertebral fractures in renal osteodystrophy . Am J Kidney Dis . 1999;33:287–293
  30. Stehman-Breen CO , Sherrard DJ , Alem AM , et al.   Risk factors for hip fracture among patients with end-stage renal disease . Kidney Int . 2000;58:2200–2205
  31. Ball AM , Gille DL , Sherrard D , et al.   Risk of hip fracture among dialysis and renal transplant recipients . JAMA . 2002;288:3014–3018
  32. Prior JC , Vigna YM , Schechter MT , et al.   Spinal bone loss and anovulatory disturbances . N Eng J Med . 1990;323:1221–1227
  33. Weisinger JR , Gonzalez L , Alvarez H , et al.   Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women . Kidney Int . 2000;58:331–335
  34. Cunningham J , Spague SM . Osteoporosis in chronic kidney disease . Am J Kidney Dis . 2004;43:566–571
  35. Kiel DP , Kauppila LI , Cupples LA , et al.   Bone loss and the progression of abdominal aortic calcification over a 25 year period (the Framingham Heart Study) . Calcif Tissue Int . 2001;68:271–276
  36. Nakashima A , Yorioka N , Tanji C , et al.   Bone mineral density may be related to atherosclerosis in hemodialysis patients . Osteoporos Int . 2003;14:369–373
  37. Tintut Y , Demer LL . Recent advances in multifactorial regulation of vascular calcification . Curr Opin Lipidol . 2001;12:555–560
  38. Demer LL . Vascular calcification and osteoporosis (inflammatory responses to oxidized lipids) . Int J Epidemiol . 2002;31:737–741
  39. Parhami F , Demer LL . Arterial calcification in face of osteoporosis in ageing (Ccan we blame oxidized lipids?) . Curr Opin Lipidol . 1997;8:312–314
  40. Hofbauer LC , Schoppet M . Osteoprotegerin (A link between osteoporosis and arterial calcification?) . Lancet . 2001;358:257–259
  41. Bucay N , Sarosi I , Dunstan CR , et al.   Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification . Genes Dev . 1998;12:1260–1268
  42. Min H , Morony S , Sarosi I , et al.   Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis . J Exp Med . 2000;192:463–474
  43. Chen NX , Moe SM . Vascular calcification in chronic kidney disease . Semin Nephrol . 2004;24:61–68
  44. Reslerova M , Moe SM . Vascular calcification in dialysis patients (Pathogenesis and consequences) . Am J Kidney Dis . 2003;41(suppl):S96–S99
  45. Bostrom KI . Cell differentiation in vascular calcification . Z Kardiol . 2000;89(suppl):S69–S74
  46. Davies MR , Lund RJ , Hruska KA . BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure . J Am Soc Nephrol . 2003;14:1559–1567
  47. Burnett JR , Vasikaran SD . Cardiovascular disease and osteoporosis (Is there a link between lipids and bone?) . Ann Clin Biochem . 2002;39:203–210
  48. Mody N , Parhami F , Sarafian TA , et al.   Oxidative stress modulates osteoblastic differentiation of vascular and bone cells . Free Radic Biol Med . 2001;31:509–519
  49. Price PA , Faus SA , Williamson MK . Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption . Arterioscler Thromb Vasc Biol . 2001;21:817–824
  50. Shlipak MG , Simon JA , Grady D , et al.   Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease . J Am Coll Cardiol . 2001;38:705–711
  51. Shlipak MG , Stehman-Breen C , Vittinghoff E , et al.   Creatinine levels and cardiovascular events in women with heart disease (Do small changes matter?) . Am J Kidney Dis . 2004;43:37–44
  52. Lazarus JM , Bourgoignie JJ , Buckalew VM , et al.   Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group . Hypertension . 1997;29:641–650
  53. Feldman HI , Appel LJ , Chertow GM , et al.   The Chronic Renal Insufficiency Cohort (CRIC) Study (Design and methods) . J Am Soc Nephrol . 2003;14(suppl):S148–S153
  54. Writing Group for the Women’s Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women (Principal results from the Women’s Health Initiative Randomized Controlled Trial) . JAMA . 2002;288:321–333
  55. Grady D , Herrington D , Bittner V , et al.   Cardiovascular disease outcomes during 6.8 years of hormone therapy (Heart and Estrogen/Progestin Replacement Study follow-up (HERS II)) . JAMA . 2002;288:49–57
  56. Hernández E , Valera R , Alonzo E , et al.   Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis . Kidney Int . 2003;63:2269–2274
  57. Yaffe K , Lui L , Grady D , et al.   Cognitive decline in women in relation to non-protein bound oestradiol concentrations . Lancet . 2000;356:708–712
  58. Resnick SM , Maki PM , Golski S , et al.   Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance . Horm Behav . 1998;34:171–182
  59. Gil-Cunqueiro JM , Garcia-Cortez MJ , Foronda J , et al.   Health related quality of life in elderly patients in hemodialysis . Nefrologia . 2003;23:528–537

 This study was supported by grant G-97-008808 of the Fondo Nacional de Ciencia, Tecnología y Innovación de Venezuela (FONACIT) and Fundarenal-HUC.

PII: S1548-5595(04)00122-3

doi: 10.1053/j.ackd.2004.07.009

Advances in Chronic Kidney Disease
Volume 11, Issue 4 , Pages 361-370 , October 2004

Article Tools